U.S. News & World Report Ranks HP&M as Top Tier FDA Law Firm for 2017 - 7th Year in a Row!
HP&M's FDA Law Blog once again chosen as an ABA Journal's Blawg 100.
Recent FDA Law Blog Entries from www.fdalawblog.net
Public Citizen Suit Highlights FDA’s Delays in Updating OTC Drug Monographs
CDRH Issues Final Guidance Regarding Interoperable Medical Devices
FDA to Hold Meeting on Home Collection of Pap Smears: Possible Broader Implications?
Fifth Circuit Upholds Summary Judgment for Solvay Pharmaceuticals in Off-Label and Anti-Kickback FCA Case
Articles and Presentations
The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials
July 27, 2017
Congress Seeks a Statutory Fix to Stymied Off-Label Discussions
May 2, 2017
DOJ Uses False Claims Act to Enforce FDA Manufacturing Rules
April 7, 2017
LDTs: The Saga Continues
The Problem of the ‘Intended Use’ Regulations Continues to Fester
March 21, 2017